The impact of universal access to DAA and real-world treatment outcome amongst genotype 3 hepatitis C virus-infected prisoners

被引：0
|
作者：
Wong, Yu Jun [1 ]
Manejero, Fria May Gloriba [1 ]
Lim, Kim Wei [1 ]
Chong, Sin Yoong [1 ]
Mai, Linn War [1 ]
Kumar, Rahul [1 ]
Teo, Eng Kiong [1 ]
Tan, Jessica [1 ]
Hsiang, John Chen [2 ]
Thurairajah, Prem Harichander [1 ]
机构：
[1] Changi Gen Hosp, Gastroenterol & Hepatol, Singapore, Singapore
[2] Sengkang Gen Hosp, Gastroenterol & Hepatol, Singapore, Singapore
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU354
引用
收藏
页码：S313 / S313
页数：1
相关论文
共 50 条
  • [31] Real-World Effectiveness of Ledipasvir/Sofosbuvir in 4,365 Treatment-Naive, Genotype 1 Hepatitis C-Infected Patients
    Backus, Lisa I.
    Belperio, Pamela S.
    Shahoumian, Troy A.
    Loomis, Timothy P.
    Mole, Larry A.
    HEPATOLOGY, 2016, 64 (02) : 405 - 414
  • [32] Individualizing treatment duration in hepatitis C virus genotype 2/3-infected patients
    Mangia, Alessandra
    LIVER INTERNATIONAL, 2011, 31 (01) : 36 - 41
  • [33] Inadvertent "off label" DAA treatment in the real-world and importance for virologic outcome - data from the German hepatitis C-Registry (DHC-R)
    Buggisch, Peter
    Schmitt, Annika
    Mauss, Stefan
    Boeker, Klaus
    Klinker, Hartwig
    Stoehr, Albrecht
    Heyne, Renate
    Cornberg, Markus
    Sarrazin, Christoph
    JOURNAL OF HEPATOLOGY, 2020, 73 : S335 - S335
  • [34] Effectiveness of sofosbuvir and ledipasvir/sofosbuvir based regimens in hepatitis C virus genotype 3 infection: real-world data from Georgian hepatitis C elimination program
    Tsertsvadze, T.
    Chkhartishvili, N.
    Abutidze, A.
    Sharvadze, L.
    Kerashvili, V.
    Kamkamidze, G.
    Zakalashvili, M.
    Skaggs, B.
    Gvinjilia, L.
    Shadaker, S.
    Nasrullah, M.
    Gamkrelidze, A.
    Kvaratskhelia, V.
    Zeuzem, S.
    Afdhal, N.
    Arora, S.
    Thornton, K.
    Averhoff, F.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S281 - S282
  • [35] Safety and Efficacy of Sofosbuvir with Ribavirin® in Hepatitis C, Genotype 3 Patients with Cirrhosis: A Real-world Experience
    Butt, Nazish
    Akhar, Ali
    Abbasi, Amanullah
    Reema, Sehrish
    Bin Bagar, Jaffer
    Shaikh, Qurban Hussain
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (02)
  • [36] Real-world effectiveness of daclatasvir plus sofosbuvir and velpatasvir/sofosbuvir in hepatitis C genotype 2 and 3
    Belperio, Pamela S.
    Shahoumian, Troy A.
    Loomis, Timothy P.
    Mole, Larry A.
    Backus, Lisa I.
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : 15 - 23
  • [37] The impact of unrestricted access to direct-acting antiviral among 1001 incarcerated hepatitis C virus-infected patients
    Wong, Yu Jun
    Thurairajah, Prem Harichander
    Kumar, Rahul
    Law, Ngai Moh
    Chong, Sin Yoong
    Ang, Tiing Leong
    Tan, Jessica
    Teo, Eng Kiong
    JOURNAL OF HEPATOLOGY, 2021, 75 : S765 - S765
  • [38] Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir as a hepatitis C virus infection salvage treatment
    Janjua, Naveed
    Wilton, James
    Cook, Darrel
    Wong, Stanley
    Butt, Zahid
    Bartlett, Sofia
    Pearce, Margo
    Ramji, Alnoor
    Yoshida, Eric
    Yu, Amanda
    Alvarez, Maria
    Binka, Mawuena
    Krajden, Mel
    JOURNAL OF HEPATOLOGY, 2020, 73 : S356 - S357
  • [39] REAL-WORLD EFFECTIVENESS OF SOFOSBUVIR / VELPATASVIR/VOXILAPREVIR AS A HEPATITIS C VIRUS INFECTION SALVAGE TREATMENT
    Krajden, Mel
    Cook, Darrel
    Wong, Stanley
    Wilton, James
    Butt, Zahid Ahmad
    Bartlett, Sofia
    Pearce, Margo
    Ramji, Alnoor
    Yoshida, Eric M.
    Yu, Amanda
    Alvarez, Maria Jose
    Binka, Mawuena
    Janjua, Naveed
    HEPATOLOGY, 2019, 70 : 914A - 914A
  • [40] The impact of IFNL3 genotype on interferon treatment outcome in patients chronically infected with hepatitis B virus: A meta-analysis
    Zhao, Zhongyi
    Qin, Zhen
    Zhou, Linlin
    Xiang, Li
    You, Jiangzhou
    Cao, Ranran
    Wang, Hongren
    Wang, Baoning
    Li, Mingyuan
    MICROBIAL PATHOGENESIS, 2019, 134
12345